SCHEMBL4846635

SCHEMBL4846635

COc1ccc(C(=O)C=Cc2cc(-c3cc(C)cc(C)c3)ccc2OCCN(C)C)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
HPGD P15428 2/20 0.48
GAA P10253 2/20 0.47
ALDH1A1 P00352 2/20 0.47
ALOX12 P18054 1/20 0.47
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
TNFRSF1A P19438 1/20 0.42
MAPT P10636 3/20 0.42
APP P05067 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
PTPN1 P18031 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4853788 0.94 MEN1 (0.40) LMNAMEN1KMT2AHPGDGAA
SCHEMBL4852466 0.90 MAPT (0.42) LMNAMEN1KMT2AHPGDGAA
SCHEMBL4846630 0.90 MAPT (0.42) LMNAMEN1KMT2AHPGDGAA
SCHEMBL4854497 0.90 MEN1 (0.48) LMNAMEN1KMT2AHPGDGAA
SCHEMBL4855883 0.90 HPGD (0.52) LMNAMEN1KMT2AHPGDGAA
SCHEMBL14280890 0.89 PDE4A (0.46) LMNAMEN1KMT2AGAAALDH1A1
SCHEMBL4848333 0.89 PDE4A (0.46) LMNAMEN1KMT2AGAAPDE4A
SCHEMBL14280885 0.89 PDE4A (0.46) LMNAMEN1KMT2AGAAPDE4A
SCHEMBL4852271 0.89 PDE4A (0.46) LMNAMEN1KMT2AGAAALDH1A1
SCHEMBL4854072 0.89 KDR (0.41) LMNAMEN1KMT2AHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed